Skip to main content

Boehringer Ingelheim FENS Research Award 2004 for outstanding neuroscience research

Pressmeddelande   •   Jul 12, 2004 09:54 CEST

Ingelheim/Germany, 12 July 2004 - The Boehringer Ingelheim FENS Research Award was presented for the second time at this year’s congress of the Federation of European Neuroscience Societies (FENS) in Lisbon from 10 to 14 July 2004. The prize, which consists of a sum of EUR 25,000 donated by Boehringer Ingelheim, is awarded to young scientists in Europe for outstanding work in the field of neuroscience research. "We appreciate that Boehringer Ingelheim can offer the FENS Research Award and is in the position of making a contribution to the advancement of young scientists," says Dr Barner, Vice-Chairman of the Board, Corporate Board Division Pharma Research, Development and Medicine at Boehringer Ingelheim.

The Boehringer Ingelheim FENS Research Award 2004, which consists of both a certificate and prize money, was given to the 38-year-old Dr Isabelle Mansuy for her outstanding studies on molecular mechanisms underlying learning and memory. "It is a great honour for me to receive this award. I deeply appreciate the recognition of our work" said Dr Mansuy, who currently conducts research at the Institute of Cell Biology of the Swiss Federal Institute of Technology in Zurich, Switzerland. "The results of our research contribute to a better understanding of the mechanisms of learning and memory formation and may open new ways to therapy against dementia and cognitive impairment in the future", she added.

The prize was presented by Professor Dieter Hinzen, Head of Boehringer Ingelheim’s largest research and development centre in Biberach an der Riss in Germany: "By sponsoring the Boehringer Ingelheim FENS Research Award, Boehringer Ingelheim demonstrates its commitment to central nervous system research. This emphasises our support for basic research in neurosciences, leading to scientific progress and the development of therapeutic innovations," Professor Hinzen said. The speech in Dr Mansuy’s honour was delivered by Professor Pierre J. Magistretti, President of the Federation of European Neuroscience Societies (FENS).

Dr Isabelle Mansuy has made a major impact on European neuroscience through her pioneering research on the application of the inducible tet system to the study of synaptic plasticity and learning. Her work constitutes a formidable demonstration of the power of the inducible transgenic approach to the elucidation of mnemonic mechanisms in the mammalian brain.

The Federation of European Neuroscience Societies (FENS)
The Federation of European Neuroscience Societies (FENS) is an organisation of all national neuroscience societies and many other societies in the field of neuroscience in Europe. FENS was established to advance research and education in the field of neuroscience. Since the first FENS Forum in Berlin in 1998 with 4,000 delegates, the attendance of the FENS Forum Meetings has been steadily growing, with over 5,500 delegates in Brighton in June 2000 and 5,300 delegates in Paris in July 2002. This is a clear indication that the Federation of European Neuroscience Societies has succeeded in its main endeavour to bring European and non-European scientists together. For more information on FENS, please see the Internet website www.fens.org.

Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 152 affiliates in 45 countries and more than 34,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2003, Boehringer Ingelheim posted net sales of 7.4 billion euro while spending more than one fifth of net sales in its largest business segment Prescription Medicines on research and development.

Research and development are conducted in several R&D centres worldwide. One of the therapeutic areas focuses on diseases of the central nervous system.

Notes to the editor
The Boehringer Ingelheim website offers under the chapter "Research & Development" a section dedicated to the Boehringer Ingelheim FENS Research Award in the sub-chapter "Awards & fellowships".

Related links:
Photo of the prizewinner 2004 Dr Isabelle Mansuy
More information about the Boehringer Ingelheim FENS Research Award 2004
Global website on FENS

Contact:
Boehringer Ingelheim GmbH
Corporate Division Communications
Kerstin Felix
55216 Ingelheim am Rhein
GERMANY
Phone: +49/6132/77 90 40 0
Fax: +49/6132/77 66 01
E-mail